Stockreport

ADC Therapeutics SA (NYSE:ADCT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]

ADC Therapeutics SA Common Shares  (ADCT) 
PDF The early response was not positive, with shares down 6.8% to US$4.41 in the past week. The results overall were pretty much dead in line with analyst forecasts; revenue [Read more]